Browsing Category
Pharma Industry News
4751 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
AstraZeneca moves deeper into cell therapy with $1bn EsoBiotec acquisition
AstraZeneca’s $1 billion acquisition of EsoBiotec signals a major shift in cell therapy innovation. Find out how this deal could transform cancer treatment.
Haleon to repurchase ÂŁ170M in shares as Pfizer completes exit
Haleon repurchases ÂŁ170M in shares as Pfizer exits its stake. Find out how this impacts stock performance, investor sentiment, and future growth.
Johnson & Johnson’s $55bn bet: What it means for healthcare and investors
Johnson & Johnson is investing $55 billion in U.S. manufacturing, R&D, and technology, reinforcing its leadership in pharmaceuticals. Find out more.
Glenmark Pharmaceuticals expands U.S. OTC market presence with Olopatadine Eye Drops
Glenmark secures FDA approval for its OTC Olopatadine Hydrochloride eye drops, expanding its U.S. presence in the $50.7M allergy relief market.
Novartis wins FDA approval for Fabhalta, the first treatment for C3 glomerulopathy
Novartis secures FDA approval for Fabhalta, the first-ever treatment for C3G. Find out how this breakthrough impacts patients and investors.
BioMarin shares rise as new VOXZOGO and PALYNZIQ data reinforce market potential
Discover how BioMarin’s latest clinical data on VOXZOGO and PALYNZIQ at ACMG 2025 offers promising insights into rare disease treatments and what it means for the market.
Piramal Pharma expands into paediatric critical care with UK approval for Neoatricon
Piramal Pharma’s Neoatricon secures UK approval, revolutionizing paediatric critical care. Learn how this breakthrough will reshape neonatal hypotension treatment.
Quiver Bioscience joins forces with Dup15q Alliance to develop ASO therapy for rare neurological disorder
Quiver Bioscience partners with the Dup15q Alliance to advance antisense oligonucleotide therapy for Dup15q syndrome. Discover how AI-driven research is shaping genetic medicine.
Can AI speed up drug discovery? Sapio and NVIDIA’s latest move suggests it can
Discover how Sapio Sciences is advancing AI-powered drug discovery with NVIDIA BioNeMo integration, transforming molecular modeling and drug research.
Zydus Lifesciences enters $1.09bn prostate cancer drug market with USFDA green light
Zydus Lifesciences gains USFDA approval for Apalutamide Tablets, 60 mg, expanding its oncology generics portfolio. Find out what this means for investors.